Ro 25-6981, a highly potent and selective blocker of N-methyl-D- aspartate receptors containing the NR2B subunit. Characterization in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1285-1292

  Fischer, G ^a   Mutel, V ^a   Trube, G ^a   Malherbe, P ^a   Kew, J N C ^a   Mohacsi, E ^a   Heitz, M P ^a   Kemp, J A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; CALCIUM ION; DIZOCILPINE; GLUCOSE; GLUTAMIC ACID; IFENPRODIL; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYGEN; POTASSIUM ION; RECEPTOR SUBTYPE; SODIUM ION; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; GLUCOSE METABOLISM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION; XENOPUS;

ANIMALS; CALCIUM CHANNELS; CELLS, CULTURED; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PHENOLS; PIPERIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNELS;

EID: 0031443289     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. AKAIKE, N., KOSTYUK, P. G. AND OSIPCHUK, Y. Y.: Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurons. J. Physiol. 412: 181-195, 1989.
2. BENVENISTE, M. AND MAYER, M. L.: Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J. Physiol. (Lond) 464: 131-163, 1993.
3. BITON, B., GRANGER, P., CARREAU, A., DEPOORTERE, H., SCATTON, B. AND AVENET, P.: The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltageoperated Ca2+ channels in rat cultured cortical neurons. Eur. J. Pharmacol. 257: 297-301, 1994.
4. BLAHOS, J.2ND AND WENTHOLD, R. J.: Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits. J. Biol. Chem. 271: 15669-15674, 1996.
5. BULLOCK, R., GRAHAM, D. I., CHEN, M. H., LOWE, D. AND MCCULLOCH, J.: Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J. Cereb. Blood Flow Metab. 10: 668-674, 1990.
6. CARTER, C., BENAVIDES, J., LEGENDRE, P., VINCENT, J. D., NOEL, F., THURET, F., LLOYD, K. G., ARBILLA, S., ZIVKOVIC, B., MACKENZIE, E. T. AND AL, E.: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J. Pharmacol. Exp. Ther. 247: 1222-1232, 1988.
7. CATTERALL, W. A.: Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol. 20: 15-43, 1980.
8. CHENARD, B. L., SHALABY, I. A., KOE, B. K., RONAU, R. T., BUTLER, T. W., PROCHNIAK, M. A., SCHMIDT, A. W. AND FOX, C. B.: Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J. Med. Chem. 34: 3085-3090, 1991.
9. CHOI, D. W., KOH, J. Y. AND PETERS, S.: Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8: 185-196, 1988.
10. CHURCH, J., FLETCHER, E. J., BAXTER, K. AND MACDONALD, J. F.: Blockade by ifenprodil of high voltage-activated Ca2 + channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N- methyl-Daspartate receptor antagonist actions. Br. J. Pharmacol. 113: 499-507, 1994.
11. DURAND, G. M., BENNETT, M. V. AND ZUKIN, R. S.: Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 90: 6731-6735, 1993.
12. FARRANT, M., FELDMEYER, D., TAKAHASHI, T. AND CULL CANDY, S. G.: NMDA-r receptor channel diversity in the developing cerebellum. Nature 368: 335-339, 1994.
13. FISCHER, G., BOURSON, A., KEMP, J. A. AND LOREZ, H. P.: The neuroprotective activity of Ro 25-6981, a NMDA receptor NR2B subtype selective blocker. Soc. Neurosci. Abstr. 22: part 3, 1760, 1996.
14. GALLAGHER, M. J., HUANG, H., PRITCHETT, D. B. AND LYNCH, D. R.: Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271: 9603-9611, 1996.
15. GILL, R., HARGREAVES, R. J. AND KEMP, J. A.: The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687,414) in a rat model of focal ischaemia. J. Cereb. Blood Flow Metab. 15: 197-204, 1995.
16. GOLDBERG, M. P. AND CHOI, D. W.: Combined oxygen and glucose deprivation in cortical cell culture: Calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13: 3510-3524, 1993.
17. GOTTI, B., DUVERGER, D., BERTIN, J., CARTER, C., DUPONT, R., FROST, J., GAUDILLIERE, B., MACKENZIE, E. T., ROUSSEAU, J., SCATTON, B. AND WICK, A.: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 247: 1211-1221, 1988.
18. GRAHAM, D., DARLES, G. AND LANGER, S. Z.: The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies. Eur. J. Pharmacol. 226: 373-376, 1992.
19. GRIMWOOD, S., GILBERT, E., RAGAN, C. I. AND HUTSON, P. H.: Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites. J. Neurochem. 66: 2589-2595, 1996a.
20. GRIMWOOD, S., LE BOURDELLES, B., ATACK, J. R., BARTON, C., COCKETT, W., COOK, S. M., GILBERT, E., HUTSON, P. H., MCKERNAN, R. M., MYERS, J., RAGAN, C. I., WINGROVE, P. B. AND WHITING, P. J.: Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes. J. Neurochem. 66: 2239-2247, 1996b.
21. GRYNKIEWICZ, G., POENIE, M. AND TSIEN, R. Y.: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
22. HESS, S. D., DAGGETT, L. P., CRONA, J., DEAL, C., LU, C.-C., URRUTIA, A., CHAVEZ-NORIEGA, L., ELLIS, S. B., JOHNSON, E. C. AND VELIÇELEBI, G.: Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 278: 808-816, 1996.
23. JOHNSON, J. W. AND ASCHER, P.: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529-531, 1987.
24. KEMP, J. A., TRUBE, G. AND KEW, J. N. C.: Ifenprodil and Ro 25-6981 are activity-dependent antagonists of NMDA NR2B subunit containing receptors. Soc. Neurosci. Abstr. 22: part 3, 1760, 1996.
25. KENDRICK, S. J., LYNCH, D. R. AND PRITCHETT, D. B.: Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits. J. Neurochem. 67: 608-616, 1996.
26. KEW, J. N. C., TRUBE, G. AND KEMP, J. A.: A novel mechanism of the activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. 497: 761-772, 1996.
27. KOH, J. AND CHOI, D. W.: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20: 83-90, 1987.
28. KUTSUWADA, T., KASHIWABUCHI, N., MORI, H., SAKIMURA, K., KUSHIYA, E., ARAKI, K., MEGURO, H., MASAKI, H., KUMANISHI, T., ARAKAWA, M., AND MISHINA, M.: Molecular diversity of the NMDA receptor channel (see comments). Nature 358: 36-41, 1992.
29. LAURIE, D. J. AND SEEBURG, P. H.: Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14: 3180-3194, 1994.
30. LUO, J., WANG, Y., YASUDA, R. P., DUNAH, A. W. AND WOLFE, B. B.: The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 51: 79-86, 1997.
31. LYNCH, D. R., LAWRENCE, J. J., LENZ, S., ANEGAWA, N. J., DICHTER, M. AND PRITCHETT, D. B.: Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: Differences with receptors formed from NR 1a and 2A. J. Neurochem. 64: 1462-1468, 1995.
32. MALHERBE, P., DRAGHUN, A., MULTHAUP, G., BEYREUTHER, K. AND MOHLER, H.: GABA-A receptor expressed from rat brain α- and β-subunit cDNAs displays potentiation by benzodiazepine receptor ligands. Mol. Brain Res. 8:199-208, 1990.
33. 3 receptor. Neuropharmacology 34: 621-629, 1995.
34. METHFESSEL, C., WITZEMANN, V., TAKAHASHI, T., MISHINA, M., NUMA, S. AND SAKMANN, B.: Patch clamp measurements on Xenopus laeuis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflügers Arch. 407: 577-588, 1986.
35. MINTA, A. AND TSIEN, R. Y.: Fluorescent indicators for cytosolic sodium. J. Biol. Chem. 264: 19449-19457, 1989.
36. MÖCKEL, V. AND FISCHER, G.: Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K. Brain Res. 648: 109-120, 1994.
37. MONYER, H., BURNASHEV, N., LAURIE, D. J., SAKWANN, B. AND SEEBURG, P. H.: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540, 1994.
38. MORI, H. AND MISHINA, M.: Structure and function of the NMDA receptor channel. Neuropharmacology 34: 1219-1237, 1995.
39. MUIR, K. W. AND LEES, K. R.: Clinical experience with excitatory amino acid antagonist drugs. Stroke 26: 503-513, 1995.
40. MULLER, W. AND CONNOR, J. A.: Dendritic spines as individual neuronal compartments for synaptic Ca2+ responses. Nature 354: 73-76, 1991.
41. NAKANISHI, N., AXEL, R. AND SHNEIDER, N. A.: Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 89: 8552-8556, 1992.
42. NETZER, R., GRAF, V., PFLIMLIN, P. AND TRUBE, G.: Effects of some NMDA receptor channel antagonists on voltage-dependent Ca2+ channels in cultured cortical neurons. In Pharmacology of Cerebral Ischemia, ed. by J. Krieglstein and H. Oberpichler-Schwenk, pp.129-137, Wissenschafftliche Verlagsgesellschaft mbH, Stuttgart, Germany, 1992.
43. PARK, C. K., NEHLS, D. G., GRAHAM, D. I., TEASDALE, G. M. AND MCCULLOCH, J.: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551, 1988.
44. PAUWELS, P. J., LEYSEN, J. E. AND JANSSEN, P. A.: Ca++ and Na+ channels involved in neuronal cell death. Protection by flunarizine. Life Sci. 48: 1881-1893, 1991.
45. PORTERA CAILLIAU, C., PRICE, D. L. AND MARTIN, L. J.: N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J. Neurochem. 66: 692-700, 1996.
46. PRIESTLEY, T., OCHU, E. AND KEMP, J. A.: Subtypes of NMDA receptor in neurones cultured from rat brain. Neuroreport 5: 1763-1765, 1994.
47. PRIESTLEY, T., LAUGHTON, P., MYERS, J., LE BOURDELLES, B., KERBY, J. AND WHITING, P. J.: Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol. 48: 841-848, 1995.
48. 3H)MK-801 binding to the N-methyl-D- aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51: 830-836, 1988.
49. REYNOLDS, I. J. AND MILLER, R. J.: Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol. Pharmacol. 36: 758-765, 1989.
50. SAUER, D., ALLEGRINI, P. R., COSENTI, A., PATAKI, A., AMACKER, H. AND FAGG, G. E.: Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study. J. Cereb. Blood Flow Metab. 13: 595-602, 1993.
51. SHALABY, I. A., CHENARD, B. L., PROCHNIAK, M. A. AND BUTLER, T. W.: Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture. J. Pharmacol. Exp. Ther. 260: 925-932, 1992.
52. SHENG, M., CUMMINGS, J., ROLDAN, L. A., JAN, Y. N. AND JAN, L. Y.: Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144-147, 1994.
53. SIGEL, E., BAUR, R. AND MALHERBE, P.: Protein kinase C transiently activated heteromeric N-methyl-D-aspartate receptor channels independent of the phosphorylatable C-terminal splice domain and of consensus phosphorylation sites. J. Biol. Chem. 269: 8204-8208, 1994.
54. TAMURA, Y., SATO, Y., YOKOTA, T., AKAIKE, A., SASA, M. AND TAKAORI, S.: Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J. Pharmacol. Exp. Ther. 265: 1017-1025, 1993.
55. TRAYNELIS, S. F., HARTLEY, M. AND HEINEMANN, S. F.: Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268: 873-876, 1995.
56. TRUBE, G., EHRHARD, P., MALHERBE, P. AND HUBER, G.: The selectivity of Ro 25-6981 for NMDA receptor subtypes expressed in Xenopus oocytes. Soc. Neurosci. Abstr. 22: part 3, 1760, 1996.
57. WARNER, D. S., MARTIN, H., LUDWIG, P., MCALLISTER, A., KEANA, J. F. AND WEBER, E.: In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J. Cereb. Blood Flow Metab. 15: 188-196, 1995.
58. WENZEL, A., SCHEURER, L., KUNZI, R., FRITSCHY, J. M., MOHLER, H. AND BENKE, D.: Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. NeuroReport 7: 45-48, 1995.
59. WENZEL, A., FRITSCHY, J. M., MOHLER, H. AND BENKE, D.: NMDA receptor herterogeneity during postnatal development of the rat brain: Differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68: 469-478, 1997.
60. WILDING, T. J. AND HUETTNER, J. E.: Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-α-methyl-4-isoxazolepropionic acid-preferring receptors. Mol. Pharmacol. 49: 540-546, 1996.
61. WILLIAMS, K.: Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44: 851-859, 1993.
62. WILLIAMS, K.: Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit. Neurosci. Lett. 184: 181-184, 1995.
63. WILLIAMS, K., RUSSELL, S. L., SHEN, Y. M. AND MOLINOFF, P. B.: Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278, 1993.
64. WILLIAMS, K., ZAPPIA, A. M., PRITCHETT, D. B., SHEN, Y. M. AND MOLINOFF, P. B.: Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol. 45: 803-809, 1994.
65. WONG, E. H., KEMP, J. A., PRIESTLEY, T., KNIGHT, A. R., WOODRUFF, G. N. AND IVERSEN, L. L.: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83: 7104-7108, 1986.
66. 3H)MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50: 274-281, 1988.
67. ZHONG, J., RUSSELL, S. L., PRITCHETT, D. B., MOLINOFF, P. B. AND WILLIAMS, K.: Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45: 846-853, 1994.
68. ZHONG, J., CARROZZA, D. P., WILLIAMS, K., PRITCHETT, D. B. AND MOLINOFF, P. B.: Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J. Neurochem. 64: 531-539, 1995.